Abstract
A patient with chronic myeloid leukaemia treated with busulphan for 4-5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice. At post-mortem there was minimal leukaemic infiltration but there were alterations in the liver architecture sufficient to explain the portal hypertension. The pathogenesis of the liver changes and their possible relationship to splenomegaly and busulphan toxicity are considered.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blendis L. M., Ansell I. D., Jones K. L., Hamilton E., Williams R. Liver in Felty's syndrome. Br Med J. 1970 Jan 17;1(5689):131–135. doi: 10.1136/bmj.1.5689.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blendis L. M., Banks D. C., Ramboer C., Williams R. Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies. Clin Sci. 1970 Jan;38(1):73–84. doi: 10.1042/cs0380073. [DOI] [PubMed] [Google Scholar]
- Datta D. V., Grover S. L., Saini V. K., Datta B. N., Aikat B. K., Chhuttani P. N. Portal hypertension in chronic leukaemia. Br J Haematol. 1975 Nov;31(3):279–285. doi: 10.1111/j.1365-2141.1975.tb00859.x. [DOI] [PubMed] [Google Scholar]